Department of Pharmaceutics and Pharmaceutical Chemistry , University of Utah , Salt Lake City , Utah 84112 , United States.
Department of Biotechnology , The Catholic University of Korea , 43-1 Yeokgok 2-dong, Wonmi-gu , Bucheon , Gyeonggi-do 420-743 , Republic of Korea.
Mol Pharm. 2018 Oct 1;15(10):4756-4763. doi: 10.1021/acs.molpharmaceut.8b00708. Epub 2018 Aug 29.
We provide immense insulin absorption from the gastrointestinal tract, combining apical sodium-dependent bile acid transporter-mediated intestinal uptake and the lymphatic transport pathway. This strategy has proven to employ chondroitin sulfate- g-taurocholic acid coated, insulin-loaded partially uncapped liposome (IPUL-CST) for type 1 diabetes mellitus (T1DM) treatment. The loading efficiency of insulin in IPUL-CST increased significantly from 33% to 75% via the partially uncapped liposome preparation method. Moreover, the IPUL-CST revealed an improved insulin protection efficacy in GIT simulated pH and digestive enzyme conditions. The high dose of IPUL-CST in the small intestine was detected 4 h post-oral administration using ex vivo optical imaging and fluorescence intensity. The IPUL-CST exhibited significantly enhanced intestinal absorption (oral bioavailability, 34%; T, 9 h) and reduced blood glucose levels for 16 h in T1DM. The results demonstrated that the new investigated IPUL-CST is a promising carrier for oral insulin delivery.
我们提供了从胃肠道中大量吸收胰岛素的方法,结合了顶端钠依赖性胆汁酸转运体介导的肠内摄取和淋巴转运途径。这种策略已被证明采用硫酸软骨素 - g-牛磺胆酸包被、载有胰岛素的部分无盖脂质体(IPUL-CST)治疗 1 型糖尿病(T1DM)。通过部分无盖脂质体制备方法,胰岛素在 IPUL-CST 中的装载效率从 33%显著提高到 75%。此外,IPUL-CST 在 GIT 模拟 pH 值和消化酶条件下显示出改善的胰岛素保护效果。口服给药 4 小时后,使用离体光学成像和荧光强度检测到小肠中高剂量的 IPUL-CST。IPUL-CST 表现出显著增强的肠道吸收(口服生物利用度,34%;T,9 h)和降低 T1DM 患者 16 小时的血糖水平。结果表明,新研究的 IPUL-CST 是一种有前途的口服胰岛素传递载体。